Arcturus Therapeutics
ARCT • NASDAQ • Stock Fundamentals
Arcturus Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Joseph E. Payne, with a market cap of $198.1M.
Market Cap$198.1M
Employees180.0
CEOJoseph E. Payne
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026
View reportNext EarningsAug 10, 2026 · in 2 monthsAfter Market Close · Q2 2026
Financials
Based on Q1 2026 filing
Arcturus Therapeutics FAQ
Common questions about Arcturus Therapeutics
Arcturus Therapeutics (ARCT) has a market capitalization of $198.1M and trades on NASDAQ.
Arcturus Therapeutics has approximately 180 employees.